Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classic Hemophilia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06369740
What this trial is testing

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring

Who this might be right for
Hemophilia a
Enzyre B.V. 74
Not applicableUnknownNCT03237273
What this trial is testing

HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound

Who this might be right for
Moderate and Severe Haemophilia
Guy's and St Thomas' NHS Foundation Trust 200
Large-scale testing (Phase 3)Study completedNCT02234323
What this trial is testing

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 108
Post-approval studies (Phase 4)Study completedNCT00950170
What this trial is testing

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Who this might be right for
Hemophilia A
Pfizer 23
Not applicableStudy completedNCT04703062
What this trial is testing

The Effects of Exercise Training in Children With Hemophilia

Who this might be right for
Hemophilia
Istanbul University - Cerrahpasa 30
Not applicableUnknownNCT02324517
What this trial is testing

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

Who this might be right for
Severe Hemophilia
Sheba Medical Center 300
Post-approval studies (Phase 4)UnknownNCT02314325
What this trial is testing

Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

Who this might be right for
Severe Haemophilia A
St. James's Hospital, Ireland 20
Post-approval studies (Phase 4)WithdrawnNCT00151385
What this trial is testing

Study Evaluating Inhibitor Specificity in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableUnknownNCT04618237
What this trial is testing

Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient

Who this might be right for
HemophiliaArthropathy
Taipei Medical University Hospital 35
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Not applicableStudy completedNCT03485170
What this trial is testing

PET Imaging of Hemophilic Arthropathy

Who this might be right for
HemophiliaArthropathyInflammation
Tri-Service General Hospital (TSGH) 20
Not applicableStudy completedNCT01959919
What this trial is testing

Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

Who this might be right for
Hemophilia A
Pfizer 86
Not applicableStudy completedNCT04584892
What this trial is testing

Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

Who this might be right for
Haemophilia A
Novo Nordisk A/S 18
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Post-approval studies (Phase 4)Study completedNCT00475072
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 14
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Large-scale testing (Phase 3)Study completedNCT01392547
What this trial is testing

Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 72
Not applicableStudy completedNCT06574984
What this trial is testing

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 329
Testing effectiveness (Phase 2)UnknownNCT01105546
What this trial is testing

RFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors

Who this might be right for
Hemophilia A With Inhibitors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 50
Not applicableLooking for participantsNCT05022459
What this trial is testing

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Who this might be right for
Hemophilia A
Wayne State University 72
Next Page